![Jessica ZUCMAN-ROSSI | Professor (Full) | MD, PhD | Centre de Recherche des Cordeliers | Research profile Jessica ZUCMAN-ROSSI | Professor (Full) | MD, PhD | Centre de Recherche des Cordeliers | Research profile](https://i1.rgstatic.net/ii/profile.image/272438818766864-1441965884512_Q512/Jessica-Zucman-Rossi.jpg)
Jessica ZUCMAN-ROSSI | Professor (Full) | MD, PhD | Centre de Recherche des Cordeliers | Research profile
![Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S001650851936771X-fx1.jpg)
Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect
![Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial - UROONCO Kidney Cancer Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial - UROONCO Kidney Cancer](https://kidney.uroonco.uroweb.org/wp-content/uploads/sites/8/RCC-logo-default-fb.png)
Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial - UROONCO Kidney Cancer
![Cancers | Free Full-Text | Sigma 1 Receptor is Overexpressed in Hepatocellular Adenoma: Involvement of ERα and HNF1α Cancers | Free Full-Text | Sigma 1 Receptor is Overexpressed in Hepatocellular Adenoma: Involvement of ERα and HNF1α](https://www.mdpi.com/cancers/cancers-12-02213/article_deploy/html/images/cancers-12-02213-g001.png)
Cancers | Free Full-Text | Sigma 1 Receptor is Overexpressed in Hepatocellular Adenoma: Involvement of ERα and HNF1α
TGFβ-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor prognosis in liver cancer - Archive ouverte HAL
![Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity - Caruso - 2021 - Hepatology - Wiley Online Library Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity - Caruso - 2021 - Hepatology - Wiley Online Library](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/cd80430e-b5eb-4583-8b8a-095424dcb966/hep.31394.fp.png)